cancer semaglutide has cause in humans GLP-1 Receptor Agonists Breast Cancer: A New Frontier in Obesity and Prognosis Management Tirzepatide and Cancer Risk in – Does semaglutide cause cancer? An

KEY OBSERVATIONS Media logos with quotes that look like theyre about GLP-1 medications generally, not Willow specifically, and no links to verify any of them

The peptide safety guide covers additional perioperative considerations

Eli Lillys tirzepatide drugs face the same criticism, since the Mounjaro label lists general gastrointestinal issues but not the severe stomach paralysis or bowel obstruction described in patient reports

Some were scams

The mechanisms of action include: Enhancement of glucose-dependent insulin secretion Suppression of glucagon secretion Delay in gastric emptying Increased satiety and appetite suppression These effects collectively lead to improved glycemic control and significant weight reduction